Actively Recruiting

Phase 4
Age: 18Years - 99Years
FEMALE
NCT05557279

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

Led by Loyola University · Updated on 2025-09-09

40

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to learn about how the use of 500 mg of dried cranberry powder extract (NDS-446) changes the bacteria that normal reside in the bladder of women who don't have urinary leakage problems but do have problems with urinary urgency and frequency.

CONDITIONS

Official Title

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

Who Can Participate

Age: 18Years - 99Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 to 99 years, ambulatory
  • Overactive bladder symptoms lasting more than 6 months
  • Voiding frequency greater than 8 times in 24 hours
  • More than 3 episodes of urgency (grade 3 or 4) without incontinence during a 3-day diary at baseline
Not Eligible

You will not qualify if you...

  • More than 3 episodes of urinary incontinence in the past month
  • More than 3 urinary tract infections in the last 12 months
  • Diagnosis of painful bladder syndrome or interstitial cystitis
  • Lower urinary tract surgery within the past 6 months
  • Drug or non-drug treatment for overactive bladder in the past 60 days
  • Current medications affecting detrusor muscle activity
  • Use of Warfarin
  • Failure to complete a 3-day urinary diary
  • Daily Aspirin dose over 81 mg
  • Gross blood in urine
  • Allergy or sensitivity to aspirin
  • Use of anti-platelet agents
  • Inability to swallow capsules

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Loyola Medical Center

Maywood, Illinois, United States, 60153

Actively Recruiting

Loading map...

Research Team

M

Mary Tulke, RN

CONTACT

E

Elizabeth Mueller, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here